Analysis of Cortical Excitability in Neuropathic Pain
1 other identifier
observational
80
1 country
1
Brief Summary
The purpose of this study is to determine whether patients with neuropathic pain has abnormal excitability in somatosensory cortex and abnormal sensory-motor connections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 10, 2008
CompletedFirst Posted
Study publicly available on registry
November 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedApril 2, 2010
March 1, 2010
3 years
November 10, 2008
April 1, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abnormal cortical excitability in motor-sensory cross-talk
non-applicable
Secondary Outcomes (1)
Genetic variability of neurotrophic factors between groups
non-applicable
Study Arms (3)
1
Healthy volunteers
2
Patient with neuropathic pain
3
patients without neuropathic pain
Eligibility Criteria
Primary care clinic healthy volunteer
You may qualify if:
- Healthy volunteers
- patients with pain resulted from dysfunction of peripheral or central nervous system
- the disorders of peripheral nerves are diagnosed by nerve conduction study, quantitative sensory test, quantification of skin innervation or contact heat evoked potentials
- lesion of central nervous system should be confirmed by neuroimage.
You may not qualify if:
- previous history of epilepsy, seizure disorders or major head injury
- previous brain surgery or intracranial metalic implant
- implanted devices as cardiac pacemaker
- pregnant subjects
- patient with severe cardiac or pulmonary disease who potentially cannot tolerate stress
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Biospecimen
Genomic polymorphism of neurotrophic factors.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ming-Kai Pan, M.D.
National Taiwan University Hospital, Department of Neurology
- STUDY DIRECTOR
Chi-Chao Chao, M.D.
National Taiwan University Hospital, Department of Neurology
- PRINCIPAL INVESTIGATOR
Sung-Tsang Hsieh, M.D. PhD
National Taiwan University Hospital, Department of Neurology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 10, 2008
First Posted
November 11, 2008
Study Start
October 1, 2008
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
April 2, 2010
Record last verified: 2010-03